CMS says Medicare Advantage and Part D coverage will remain broadly stable in 2027, with lower average premiums and continued plan choice.
CMS says Medicare Advantage and Part D coverage will remain broadly stable in 2027, with lower average premiums and continued plan choice.
House Democrats propose reversing healthcare cuts, protecting vaccine access, lowering costs, and expanding coverage in the next Congress.
Debates over leadership at the CDC and FDA underscore growing concerns about scientific independence and public trust in health agencies.
Our in-brief roundup of notable healthcare and life sciences stories from the last two weeks.
The payer group says growing use of AI-powered coding tools may be increasing hospital billing costs, while hospitals blame other factors.
FDA commissioner nominee Heidi Overton defended vaccine safety while declining to take firm positions on mifepristone reviews.
While most of the drugs reviewed were priced below the international average, nearly as many were priced above it.
CMS says it canceled unauthorized Marketplace enrollments, targeted non-compliant brokers, and added new safeguards to reduce fraud.